[HTML][HTML] Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune …
TW de Vos, M de Haas, D Oepkes, RNGB Tan… - American journal of …, 2022 - Elsevier
Background Children with fetal and neonatal alloimmune thrombocytopenia face increased
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia
TW de Vos, M de Haas, D Oepkes… - … of obstetrics and …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Children with fetal and neonatal alloimmune thrombocytopenia face increased
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
[PDF][PDF] Long-term neurodevelopmental outcome in children after antenatal intravenous immunoglobulin treatment in fetal and neonatal alloimmune thrombocytopenia
TW de Vos, M de Haas, D Oepkes… - FETAL AND … - scholarlypublications …
BACKGROUND Children with fetal and neonatal alloimmune thrombocytopenia (FNAIT)
face increased risk of intracranial hemorrhage (ICH) potentially leading to developmental …
face increased risk of intracranial hemorrhage (ICH) potentially leading to developmental …
Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia.
TW de Vos, M de Haas, D Oepkes, R Tan… - American Journal of …, 2022 - europepmc.org
Background Children with fetal and neonatal alloimmune thrombocytopenia face increased
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia
TW de Vos, M de Haas… - American …, 2022 - researchinformation.amsterdamumc …
Background: Children with fetal and neonatal alloimmune thrombocytopenia face increased
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia
TW de Vos, M de Haas, D Oepkes, RNGB Tan… - American Journal of …, 2022 - ajog.org
Background Children with fetal and neonatal alloimmune thrombocytopenia face increased
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia
TW de Vos, MD Masja de Haas, D Oepkes, RNGB Tan… - Obstet Gynecol, 2022 - ajog.org
Background Children with fetal and neonatal alloimmune thrombocytopenia face increased
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
risk of intracranial hemorrhage potentially leading to developmental impairment. To prevent …
Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia
TW de Vos, M Haas, D Oepkes… - … of Obstetrics & …, 2022 - scholarlypublications …
BACKGROUND: Children with fetal and neonatal alloimmune throm-bocytopenia face
increased risk of intracranial hemorrhage potentially leading to developmental impairment …
increased risk of intracranial hemorrhage potentially leading to developmental impairment …